Veracyte, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
VCYT on Nasdaq
Industry
Services-Medical Laboratories
Location
6000 Shoreline Court, Suite 300, South San Francisco, CA

Insiders trading volume in the past year

Veracyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Marc Stapley Chief Executive Officer, Director $10.1M Sep 2, 2024
Tina Susan Nova President, CLIA U.S. $4.78M Mar 3, 2022
Bonnie H. Anderson Director $4.68M Jun 2, 2023
Phillip G. Febbo Chief Scientific & Med Officer $4.51M Mar 6, 2024
Rebecca Chambers Chief Financial Officer $4.41M Sep 2, 2024
Annie McGuire SVP, General Counsel $2.95M Sep 2, 2024
John Leite Chief Commercial Officer-CLIA $2.27M -$195K -7.92% Sep 4, 2024
Giulia C. Kennedy Chief Scientific & Med Officer $1.75M Dec 6, 2022
Jonathan Wygant VP, Chief Accounting Officer $1.49M Sep 2, 2024
Evan/ Fa Jones Director $1.29M -$2.15M -62.4% Aug 12, 2024
John L. Bishop Director $1.28M Jul 17, 2023
Karin Eastham Director $930K -$536K -36.6% Jul 16, 2024
Robert S. Epstein Director $918K Jun 13, 2024
Eliav Barr Director $862K Jun 13, 2024
Jens Holstein Director $836K -$268K -24.2% Aug 7, 2024
Muna Bhanji Director $712K -$111K -13.5% Jun 13, 2024
David Brent Shafer Director $541K Sep 3, 2024
Thomas F. Miller Director $521K Sep 3, 2024
Jane Alley VP, Corporate Controller $345K May 17, 2021
Kevin K. Gordon Director $231K Jun 8, 2022

Recent Insider Transactions by Companies or Individuals for Veracyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.